Join the Sentynl team

Manager, Commercial Operations

The Manager, Commercial Operations will lead and oversee all aspects of Field & Marketing operations with primary responsibilities to lead and manage territory alignments, field force sizing and structure, IC reporting, data aggregation, SFA implementation/management, and ad-hoc analytics. They will contribute to the development and execution of commercial and market access strategy in the U.S. This individual will be a strategic, highly collaborative leader who will bring a significant amount of experience in building commercial operations functions. They will provide active collaboration in a fast-paced environment to ensure successful commercial execution. This individual will also support the process for reviewing marketing materials, have responsibility for medical congress efforts, and direct and manage external vendors to ensure successful execution of deliverables. In addition, they will play a key role in building brand strategy, market insight generation, and commercial performance in highly specialized therapeutic areas. The successful Manager, Commercial Operations, will need to work across a wide variety of functions and will possess a broad set of skills which will allow them to manage a variety of projects simultaneously.

Director, Business Development

The Director of Business Development will be responsible for leading the search, identification, evaluation, negotiation, and execution of licensing and acquisition opportunities that expand Sentynl’s rare disease portfolio. This role requires significant financial acumen, deep transaction experience, and the ability to lead cross-functional diligence and deal execution processes. The Director will partner closely with Commercial, Regulatory, Medical, Market Access, Legal, and Finance teams to ensure disciplined evaluation and successful integration of strategic transactions.

National Field Manager

The National Field Manager leads the team of Key Account Managers to provide education on disease states and approved products to applicable healthcare professionals and key accounts. This role will be defined as a “Player Coach” role as this person will be responsible for management of team of Key Account Managers while also taking lead on field activity in their own designated territory. Develop and execute plans to educate applicable healthcare professionals and key accounts in the United States. Works with Key Account Managers to succeed in their position while maintaining compliance with all applicable laws, regulations, industry standards and company policies.

Key Account Manager

The Key Account Manager’s primary responsibility is to educate healthcare professionals about disease states as well applicable Sentynl Therapeutics’ approved rare disease therapies while focusing on the execution of daily field activities in compliance with all applicable laws, regulations and industry standards.

Director, Clinical Operations

The Director of Clinical Operations will provide strategic and operational leadership in the planning, execution, and oversight of clinical study programs across the full development lifecycle (Phase 2/3 through Phase 4). This role is accountable for the successful delivery of studies within the Clinical Development Plan whether conducted in-house or outsourced to third-party vendors. Working cross-functionally with internal stakeholders and external partners, the Director, Clinical Operations will manage timelines, budgets, and resources while ensuring regulatory compliance and operational excellence.

Medical Science Liaison (MSL)

The hybrid Medical Science Liaison (MSL) is a field-based medical expert who communicates appropriate and applicable scientific information to clinicians and researchers working in the rare disease areas of interest to Sentynl. This individual develops, manages and maintains collegial relationships with healthcare professionals (HCPs) and other stakeholders to determine research and clinical interests, obtain external insights on existing or emerging science and to increase HCP awareness of Sentynl’s rare disease programs.